Target intelligence / Profile preview

Group B Streptococcus surface protein (GBS surface protein)

Target
GBS surface protein
Molecular classification
Surface-exposed bacterial adhesin, Bacterial cell wall-anchored protein, Virulence factor
01

Overview

Group B Streptococcus surface proteins are a diverse group of cell wall-anchored molecules expressed on the outer membrane of *Streptococcus agalactiae* that play critical roles in bacterial pathogenesis. These include well-characterized adhesins such as fibrinogen-binding proteins FbsA/B/C, serine-rich repeat glycoproteins Srr1/Srr2, laminin-binding protein Lmb, C5a peptidase ScpB, fibronectin-binding protein SfbA, and immunogenic bacterial adhesin BibA. Other notable members include the S-protein homologs and R-like antigens such as R3 and BPS. These proteins mediate adherence to host tissues and extracellular matrix components—key steps in colonization and invasion—and contribute to biofilm formation. They also interact with host immune defenses by modulating complement activation or binding inhibitory receptors on leukocytes. The diversity among these antigens complicates vaccine development due to strain-specific expression patterns. GBS surface proteins are considered important therapeutic targets for vaccine development because they can elicit protective immune responses against infection by promoting opsonophagocytosis or blocking adhesion/invasion pathways. However, no small-molecule drugs specifically targeting these molecules have been developed yet. ### Additional Notes - **Specificity**: The term "Group B streptococcus surface protein" is broad and refers collectively to several distinct molecular entities rather than a single defined receptor. - **Therapeutic Target**: True—these molecules are considered potential targets mainly for vaccines. - **Molecular Classification**: While not strictly receptors/enzymes/transporters/etc., they function primarily as virulence factors/adhesins. - **Disease Role**: Primarily involved in infection caused by Group B Streptococcus. - **Interacting Drugs/Mechanism/Biomarkers**: Currently none established beyond experimental antibody/vaccine approaches. If you require information on a specific member within this group (e.g., FbsA or R3), please specify so that more precise details can be provided.

Other names
S proteinBPS (group B protective surface) proteinR3 surface proteinFbsA/B/C (fibrinogen-binding proteins)Srr1/Srr2 (serine-rich repeat glycoproteins)Lmb (laminin-binding protein)ScpB (C5a peptidase)SfbA (fibronectin-binding protein A)BibA
02

Biological functions

Adherence to host cells and extracellular matrix proteinsMediation of bacterial interactions with host defensesPromotion of colonization, persistence, translocation and invasion of host barriersBiofilm formation
03

Disease associations

Infection
04

Safety considerations

Potential for immune evasion due to antigenic variation among strainsRisk of incomplete protection if vaccine targets only one variant

Beyond the preview

Go deeper on Group B Streptococcus surface protein (GBS surface protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Group B Streptococcus surface protein (GBS surface protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call